Hey Brucey, It's not rumor. It's in the Shareholders letter. I can't copy and paste on my phone. It's all part of Race's strategy to have peer reviewed papers printed in top scientific journals before Announcing data to get a bigger bang and more eyes on us. DCB has also mentioned this to a few SHs. And whilst the SHs letter only specifies preclinical data being peer reviewed, I speculate Doms FTO clinical data also to come to us the same way- please correct me if I'm wrong. And the reason I speculate that it wasn't included in the letter as getting peer reviewed along with some preclinical work is that Race would then have to admit it's good data and we aren't meant to know anything about it yet hence no mention while they protect clinical FTO IP. Imo. Have a goodie.
General Comments / Chat, page-8333
-
- There are more pages in this discussion • 3,740 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2372 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 141 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |